Kamada CFO discloses initial share and option stakes

Kamada Ltd. Chief Financial Officer Chaime Orlev has filed an initial Form 3 reporting his equity holdings in the company.

Rhea-AI Filing Summary

Kamada Ltd. Chief Financial Officer Chaime Orlev has filed an initial Form 3 reporting his equity holdings in the company. He directly owns 11,633 Ordinary Shares and holds several grants of options to purchase Ordinary Shares, each covering 22,500 underlying shares at exercise prices of 6.18, 6.15 and 7.55 per share, with expirations between 2028-08-28 and 2035-10-22. The options are exercisable using a net-exercise method, and the exercise prices in U.S. dollars are convenience translations from NIS based on the Bank of Israel exchange rate as of March 13, 2026.

Insider Trade Summary

10 transactions reported

Mixed 10 txns

Insider ORLEV CHAIME

Role Chief Financial Officer

Type	Security	Shares	Price	Value
holding	Options to purchase Ordinary Shares	--	--	--
holding	Options to purchase Ordinary Shares	--	--	--
holding	Options to purchase Ordinary Shares	--	--	--
holding	Options to purchase Ordinary Shares	--	--	--
holding	Options to purchase Ordinary Shares	--	--	--
holding	Options to purchase Ordinary Shares	--	--	--
holding	Options to purchase Ordinary Shares	--	--	--
holding	Options to purchase Ordinary Shares	--	--	--
holding	Options to purchase Ordinary Shares	--	--	--
holding	Ordinary Shares	--	--	--

Holdings After Transaction: Options to purchase Ordinary Shares — 202,500 contracts (Direct); Ordinary Shares — 11,633 shares (Direct)

Footnotes (2)

1. F1. These options to purchase ordinary shares are exercisable using a net-exercise method
2. F2. All exercise prices presented in U.S. dollars represent a convenience translation from NIS based on the representative exchange rate of the Bank of Israel as of March 13, 2026.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Kamada (KMDA) Form 3 filed by CFO Chaime Orlev report?

It reports CFO Chaime Orlev’s initial equity holdings in Kamada Ltd., including Ordinary Shares and stock options. Form 3 is a baseline disclosure when someone becomes an insider, showing their starting ownership before any future reportable transactions occur.

How many Kamada Ordinary Shares does CFO Chaime Orlev currently hold?

He directly holds 11,633 Ordinary Shares of Kamada Ltd. as reported in the Form 3. This figure reflects his direct ownership position and serves as a reference point for any future changes reported on subsequent insider filings.

What stock options are disclosed for Kamada’s CFO in this Form 3 filing?

The filing lists several option grants to purchase Ordinary Shares, with each line showing 22,500 underlying shares. These options have exercise prices of 6.18, 6.15 and 7.55 per share and expire between 2028-08-28 and 2035-10-22.

How were the option exercise prices determined in the Kamada CFO Form 3?

Exercise prices shown in U.S. dollars are convenience translations from NIS. The filing explains they are based on the representative exchange rate of the Bank of Israel as of March 13, 2026, providing a consistent currency reference for investors.

Does this Kamada (KMDA) Form 3 show any recent purchases or sales by the CFO?

No buying or selling activity is indicated; the entries are classified as holdings. Form 3 is meant to disclose existing ownership, so this document establishes the CFO’s starting stake in Ordinary Shares and options rather than recording new market transactions.

What does “net-exercise method” mean for Kamada CFO stock options in this filing?

The filing states that the options are exercisable using a net-exercise method. This typically allows the holder to receive fewer shares instead of paying cash for the exercise price, with shares withheld to cover the cost, simplifying option exercise for insiders.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/16/2026 - 07:01 AM Learn about SEC filing dates

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

ORLEV CHAIME

(Last) (First) (Middle)

6 DERECH EILOT ST.

(Street)

GANEI TIKVA L3 5591166

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
03/16/2026

3. Issuer Name and Ticker or Trading Symbol
KAMADA LTD [ KMDA ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Ordinary Shares	11,633	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Options to purchase Ordinary Shares(1)	05/28/2024	11/28/2029	Ordinary Shares	22,500	$6.18(2)	D
Options to purchase Ordinary Shares(1)	05/28/2025	11/28/2029	Ordinary Shares	22,500	$6.18(2)	D
Options to purchase Ordinary Shares(1)	02/28/2026	08/28/2028	Ordinary Shares	22,500	$6.15(2)	D
Options to purchase Ordinary Shares(1)	05/28/2026	11/28/2029	Ordinary Shares	22,500	$6.18(2)	D
Options to purchase Ordinary Shares(1)	10/22/2026	10/22/2035	Ordinary Shares	22,500	$7.55(2)	D
Options to purchase Ordinary Shares(1)	05/28/2027	11/28/2029	Ordinary Shares	22,500	$6.18(2)	D
Options to purchase Ordinary Shares(1)	10/22/2027	10/22/2035	Ordinary Shares	22,500	$7.55(2)	D
Options to purchase Ordinary Shares(1)	10/22/2028	10/22/2035	Ordinary Shares	22,500	$7.55(2)	D
Options to purchase Ordinary Shares(1)	10/22/2029	10/22/2035	Ordinary Shares	22,500	$7.55(2)	D

Explanation of Responses:

1. These options to purchase ordinary shares are exercisable using a net-exercise method

2. All exercise prices presented in U.S. dollars represent a convenience translation from NIS based on the representative exchange rate of the Bank of Israel as of March 13, 2026.

	/s/ Chaime Orlev	03/16/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.